Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03709706
Brief Title: Pilot Immunotherapy Study With Autologous T-cells Specific for New York Esophageal Antigen-1 (NY-ESO-1)/ Cancer-testis Antigen-2 (LAGE-1a)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

First Submitted : October 15, 2018
First Submitted that Met QC Criteria : October 15, 2018
First Posted : October 17, 2018

Last Update Submitted that Met QC Criteria : June 10, 2019
Last Update Posted : June 12, 2019